- Home
- LUCD vs CBAT Comparison
LUCD vs CBAT Comparison
Compare LUCD & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- CBAT
- Stock Information
- Founded
- LUCD 2018
- CBAT 1999
- Country
- LUCD United States
- CBAT China
- Employees
- LUCD N/A
- CBAT N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CBAT Industrial Machinery/Components
- Sector
- LUCD Health Care
- CBAT Miscellaneous
- Exchange
- LUCD Nasdaq
- CBAT Nasdaq
- Market Cap
- LUCD 108.0M
- CBAT 90.4M
- IPO Year
- LUCD 2021
- CBAT N/A
- Fundamental
- Price
- LUCD $1.13
- CBAT $0.91
- Analyst Decision
- LUCD Strong Buy
- CBAT
- Analyst Count
- LUCD 5
- CBAT 0
- Target Price
- LUCD $3.70
- CBAT N/A
- AVG Volume (30 Days)
- LUCD 655.3K
- CBAT 366.8K
- Earning Date
- LUCD 11-12-2025
- CBAT 11-10-2025
- Dividend Yield
- LUCD N/A
- CBAT N/A
- EPS Growth
- LUCD N/A
- CBAT N/A
- EPS
- LUCD N/A
- CBAT N/A
- Revenue
- LUCD $4,360,000.00
- CBAT $161,757,685.00
- Revenue This Year
- LUCD $13.30
- CBAT N/A
- Revenue Next Year
- LUCD $155.58
- CBAT $60.02
- P/E Ratio
- LUCD N/A
- CBAT N/A
- Revenue Growth
- LUCD 14.74
- CBAT N/A
- 52 Week Low
- LUCD $0.75
- CBAT $0.57
- 52 Week High
- LUCD $1.80
- CBAT $1.28
- Technical
- Relative Strength Index (RSI)
- LUCD 47.07
- CBAT 46.00
- Support Level
- LUCD $1.03
- CBAT $0.85
- Resistance Level
- LUCD $1.23
- CBAT $0.95
- Average True Range (ATR)
- LUCD 0.06
- CBAT 0.04
- MACD
- LUCD -0.02
- CBAT -0.00
- Stochastic Oscillator
- LUCD 34.62
- CBAT 35.59
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.